Perlane Celebrates Its One-Year Anniversary in U.S.
                   
primenewswire.com     May 12, 2008            

SCOTTSDALE, Ariz., May 12, 2008 (PRIME NEWSWIRE) -- Approximately one year ago, the U.S. Food and Drug Administration (FDA) approved Perlane(R), a hyaluronic acid dermal filler in the Restylane(R) family of products that has a larger particle size. Perlane(R) is injected into the deep dermis to... [read full story]                

Add a comment to the article
Type the code shown

View all news articles about:

- Related Topics

View other selected articles:

                   

Julie Deardorff: Cell phone can save you ... or kill you

chicagotribune.com     yesterday   275 related          

Your cell phone has the power to kill you or save your life. So while they do pose some risks--and we must admit, it's a little unnerving that Ronald B. Herberman, director of the University of Pittsburgh Cancer Institute, told...                

comments

                   

Topigen Completes Enrollment Of Phase II Study Of TPI ASM8 In Asthma

medicalnewstoday.com     yesterday   4 related          

TOPIGEN Pharmaceuticals Inc., a clinical-stage biopharmaceutical company specialized in developing products for respiratory disorders, has announced the completion of patient enrollment in a Phase II safety and efficacy study...                

comments

FDA urges genetic test before giving AIDS drug

stltoday.com     Jul 24, 2008   19 related          

C.2008 NEW YORK TIMES NEWS SERVICE Seeking to prevent life-threatening side effects, the Food and Drug Administration is urging doctors to use a genetic test to screen patients before prescribing a drug widely used for HIV...                

comments

                   

Medical ID Bracelet

emmyrose.com     Jul 24, 2008          

If you have a chronic illness like me or you suffer from specific illness and allergies it is vital to have a medical id bracelet so that in case of emergencies, the paramedics can respond to your medical needs and avoid making...                

comments